Literature DB >> 33715085

The effect of dietary approaches to stop hypertension (DASH) diet on attention-deficit hyperactivity disorder (ADHD) symptoms: a randomized controlled clinical trial.

Yadollah Khoshbakht1,2, Fatemeh Moghtaderi1,2, Reza Bidaki3,4, Mahdieh Hosseinzadeh1,2, Amin Salehi-Abargouei5,6.   

Abstract

BACKGROUND: The dietary approaches to stop hypertension (DASH) diet have several components like high amounts of fruits, vegetables, low-fat dairy products, and vitamin C and low amounts of simple sugars that might improve attention-deficit hyperactivity disorder (ADHD) symptoms. We aimed to investigate the effect of a DASH diet on children (aged 6-12 years) with ADHD, for the first time.
METHODS: Participants were randomized to receive a DASH or a control diet for 12 weeks. The severity of ADHD symptoms [determined by abbreviated 10-item Conner's scale (ACS), 18-item Swanson, Nolan and Pelham (SNAP-IV) scale and strengths and difficulties questionnaire (SDQ)] were assessed every four weeks.
RESULTS: Eighty children completed the study. After adjustment for confounders, parent (- 4.71 for the DASH group vs. - 3 for the control group) and teacher-reported (- 5.35 vs. - 1.87) ACS scores, parent-, teacher-, child-reported hyperactivity (- 1.40 vs. - 0.66, - 1.95 vs. -0.63, - 1.60 vs. - 0.43, respectively), emotional symptoms (- 1.50 vs. - 0.45, - 1.42 vs. - 0.63, and - 1.09 vs. - 0.61, respectively), and total SDQ scores (- 3.81 vs. - 1.65, - 4.11 vs. - 1.23, - 4.44 vs. - 1.26, respectively), teacher-reported of conduct problems (- 1.42 vs. - 0.63), peer relationship problems (- 0.87 vs. - 0.07), and prosocial behaviors (1.36 vs. 0.08) assessed by the SDQ were significantly improved in the DASH group compared with the control group (P < 0.05).
CONCLUSION: Adherence to a DASH-style diet might improve ADHD symptoms. Further RCTs which include participants from both sexes and with longer follow-up periods are needed to warrant current findings (The trial registration code: IRCT20130223012571N6; http://irct.ir/trial/12623 ). Trial registration Trial registration number: The trial was registered in the Iranian registry of clinical trials (registration code: IRCT20130223012571N6), URL: http://irct.ir/trial/12623 .

Entities:  

Keywords:  Attention-deficit disorder with hyperactivity; Children; DASH; Diet; Dietary approaches to stop hypertension; Randomized controlled clinical trial

Year:  2021        PMID: 33715085     DOI: 10.1007/s00394-021-02527-x

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  60 in total

Review 1.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

Authors:  Guilherme Polanczyk; Maurício Silva de Lima; Bernardo Lessa Horta; Joseph Biederman; Luis Augusto Rohde
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

2.  Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details.

Authors:  James Swanson; L Eugene Arnold; Helena Kraemer; Lily Hechtman; Brooke Molina; Stephen Hinshaw; Benedetto Vitiello; Peter Jensen; Ken Steinhoff; Marc Lerner; Laurence Greenhill; Howard Abikoff; Karen Wells; Jeffery Epstein; Glen Elliott; Jeffrey Newcorn; Betsy Hoza; Timothy Wigal
Journal:  J Atten Disord       Date:  2008-07       Impact factor: 3.256

3.  Amino acid supplementation as therapy for attention deficit disorder.

Authors:  E D Nemzer; L E Arnold; N A Votolato; H McConnell
Journal:  J Am Acad Child Psychiatry       Date:  1986-07

Review 4.  Attention-deficit/hyperactivity disorder: a selective overview.

Authors:  Joseph Biederman
Journal:  Biol Psychiatry       Date:  2004-12-18       Impact factor: 13.382

Review 5.  Diet in the treatment of ADHD in children - a systematic review of the literature.

Authors:  Maren Johanne Heilskov Rytter; Louise Beltoft Borup Andersen; Tine Houmann; Niels Bilenberg; Allan Hvolby; Christian Mølgaard; Kim F Michaelsen; Lotte Lauritzen
Journal:  Nord J Psychiatry       Date:  2014-06-16       Impact factor: 2.202

6.  Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later.

Authors:  Rachel G Klein; Salvatore Mannuzza; María A Ramos Olazagasti; Erica Roizen; Jesse A Hutchison; Erin C Lashua; F Xavier Castellanos
Journal:  Arch Gen Psychiatry       Date:  2012-12

7.  Effects of megavitamin therapy on children with attention deficit disorders.

Authors:  R H Haslam; J T Dalby; A W Rademaker
Journal:  Pediatrics       Date:  1984-07       Impact factor: 7.124

8.  Treatment of hyperactive children with D-phenylalanine.

Authors:  A J Zametkin; F Karoum; J L Rapoport
Journal:  Am J Psychiatry       Date:  1987-06       Impact factor: 18.112

Review 9.  The age at onset of attention deficit hyperactivity disorder.

Authors:  Christian Kieling; Renata R Kieling; Luis Augusto Rohde; Paul J Frick; Terrie Moffitt; Joel T Nigg; Rosemary Tannock; Francisco Xavier Castellanos
Journal:  Am J Psychiatry       Date:  2010-01       Impact factor: 18.112

10.  Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].

Authors:  Shahin Akhondzadeh; Mohammad-Reza Mohammadi; Mojgan Khademi
Journal:  BMC Psychiatry       Date:  2004-04-08       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.